Aveanna Healthcare (Nasdaq: AVAH) reported vital income development within the second quarter of 2025 throughout Thursday's win, primarily pushed by private-duty companies (PDS) and residential well being. “Our outcomes of the second quarter mirror the fixed optimistic momentum in all three operational divisions, whereas we navigate of our strategic transformation via the third 12 months,” stated CEO Jeff Shaner through […]
